Peptide record

TPDB93205

Angiopep2 Blood-Brain Barrier Cell-penetrating Peptides modified_plain modified
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB93205
Angiopep2
Blood-Brain Barrier Cell-penetrating Peptides
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia CPPsite3.0
modified_plain
Yes
A 19-aa modified multi-activity (Blood-Brain Barrier and Cell-penetrating Peptides) peptide sequence curated from B3Pred, BBPpredict, Peptipedia, and other sources, with an available 3D structural model.
Chemical: FITC-labeled polymersomes (Ps)
Sequence
TFFYGGCRGKRNNFKTEEY
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
19 reviewed residue count
Free Activity
FITC-labeled polymersomes (Ps) Activity
L Activity
Linear Activity
Free Activity
N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(=O)O Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

U87Mg Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L
Protein derived
Doxorubicin (DOX)
The angiopep2-modified Ps were uptaken more efficiently than the unmodified Ps, showing 5 times more internalization by the U86MG cells.
Receptor mediated endocytosis
In vitro
CCSCC
Additional Detail Fields 1 fields
CCSCC